Page 12 - Reportable Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AIM Biotech Reviews Techniques to Improve T Cell Efficacy Using the Company's Organ-on-a-Chip Technology (3D Cell Culture Plate) Reportable 27 Jul 2021, 04:38 GMT+10 Singapore & Boston, MA -- July 26, 2021 -- AIM Biotech is providing an update on a technique using its organ-on-a-chip platform to further improve T cell efficacy. The Company's 3D cell culture chips are being used in preclinical research to better understand Adoptive T Cell Immunotherapy, and, specifically, improve cancer treatment options with allogeneic (universal donor) engineered T Cells that could have fewer off target effe...

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial Reportable 15 Jun 2021, 01:16 GMT+10 Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial GAITHERSBURG, Md., June 14, 2021 - Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoi...

Dubai, United Arab Emirates--(Newsfile Corp. - May 26, 2021) - Coming out of stealth after more than a year of research and development,

Reportable, Inc.: New Machine Learning Platform neurothink to Disrupt Industry, Launches at AIBC Summit Dubai To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: New machine learning technology platform coming out of stealth at AIBC Summit in Dubai after more than a year of research and development. neurothink was founded to eliminate the frustrations caused by data science interfaces and inefficient GPU access while using typical cloud service provider platforms. neurothink focuses on making machine learning more readily available. neur...

Bolle Develops First High-Contrast Lens Using Artificial Intelligence Reportable Bolle Develops First High-Contrast Lens Using Artificial Intelligence LYON, FRANCE (May 25, 2021) - Bolle is launching the most technologically advanced high contrast lens in the marketplace with the introduction of Volt +, Bolle's first lens ever developed using Artificial Intelligence (AI). The Volt + lens is the latest innovation to come out of EPIC, Bolle's new state-of-the-art design and technology innovation lab based in Lyon, France. The lens technology will be included throughout Bolle's line of sport and...